Public Company News

CARsgen Receives CTA Authorization from Health Canada for CLDN18.2-targeted CAR T-cell Product CT041

SHANGHAI, Nov. 22, 2021 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company mainly focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, today announced that the Company has received a No Objection Letter from...

2021-11-22 20:00 2952

Scienjoy Holding Corporation Reports Interim Nine months ended September 30, 2021 Unaudited Financial Results

BEIJING, Nov. 22, 2021 /PRNewswire/ -- Scienjoy Holding Corporation ("Scienjoy", the "Company", or "We") (NASDAQ: SJ), a leading live entertainment mobile streaming platform inChina, today announced its unaudited financial results for the nine months endedSeptember 30, 2021. Nine Months 2021 Ope...

2021-11-22 20:00 3032

Baidu Enters Into License Agreement With Sanofi to Enable Next-Generation mRNA Therapeutics and Vaccines

BEIJING, Nov. 22, 2021 /PRNewswire/ -- Baidu, Inc. (NASDAQ:BIDU and HKEX:9888), a leading AI company with strong Internet foundation, and Sanofi, a leading biopharmaceutical company focused on human health, have entered into an agreement to integrate Baidu's messenger ribonucleic acid (mRNA) desi...

2021-11-22 20:00 2667

ReneSola Power to Release Third Quarter 2021 Financial Results on December 7, 2021

STAMFORD, Conn., Nov. 22, 2021 /PRNewswire/ -- ReneSola Ltd ("ReneSola Power" or the "Company") (www.renesolapower.com ) (NYSE: SOL), a leading fully integrated solar project developer, announced today that it will report its unaudited financial results for the thir...

2021-11-22 19:00 2244

Meten Holding Group Ltd. Announces Financial Results for the Third Quarter and the Nine Months Ended September 30, 2021

SHENZHEN, China, Nov. 22, 2021 /PRNewswire/ -- Meten Holding Group Ltd. ("Meten Holding Group" or the "Company") (NASDAQ: METX), one of the leading omnichannel English language training ("ELT") service providers in China, today announced its unaudited financial results for the third quarter and t...

2021-11-22 19:00 2244

Bud APAC Selected as Constituent of the Dow Jones Sustainability Asia Pacific Index for the First Time

HONG KONG, Nov. 22, 2021 /PRNewswire/ -- Budweiser Brewing Company APAC ("Bud APAC", SEHK:1876) announced today that it has been selected as a constituent of the Dow Jones Sustainability Asia Pacific Index for the first time. The Dow Jones Sustainability Asia Pacific Index inclusion underscores...

2021-11-22 17:42 4094

Tuya Highlighted in Gartner Report on Digital Transformation, Strengthens Global Business

DÜSSELDORF, Germany, Nov. 22, 2021 /PRNewswire/ -- Tuya Smart (NYSE: TUYA), a leading global IoT development platform, has been included as a Sample Vendor in Gartner's recently released report, Gartner Hype Cycle for Digital Business Capabilities, 2021, that focuses on wide-scale digital change ...

2021-11-22 17:08 3743

Zhihu Inc. Reports Third Quarter 2021 Unaudited Financial Results

BEIJING, Nov. 22, 2021 /PRNewswire/ -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE: ZH), the operator of Zhihu, a leading online content community inChina, today announced its unaudited financial results for the quarter endedSeptember 30, 2021. Third Quarter 2021 Highlights * Average monthly ...

2021-11-22 17:03 4043

Ooredoo's Digital Transformation Continues with Tecnotree as New Digital Billing Vendor

HELSINKI, Nov. 22, 2021 /PRNewswire/ -- Continuing to pioneer the latest technologies and solutions, Ooredoo Oman has signed an agreement withFinland -based digital business support system (BSS) provider, Tecnotree, as a vendor for its digital billing system. Based on microservices architecture, t...

2021-11-22 16:59 2066

Arriver™ to Support Qualcomm's Technology Collaboration With BMW With Vision Perception Software for Automated Driving

STOCKHOLM, Nov. 22, 2021 /PRNewswire/ -- Arriver, the ADAS and AD software unit of Veoneer, announces today that, via its existing Master Collaboration Agreement with Qualcomm Technologies, Inc., will provide Vision Perception software as part of Qualcomm Technologies' announcement with BMW to br...

2021-11-22 16:46 4039

OnMobile Global Launches O-Cade with Ooredoo Myanmar

BENGALURU, India, Nov. 22, 2021 /PRNewswire/ -- OnMobile Global Limited ("OnMobile"), the global leader in mobile entertainment, has launched their new B2B mobile quiz gaming product, Challenges Arena, under the brand nameO-Cade with Ooredoo Myanmar.This is one of 6 partnerships which have gone l...

2021-11-22 15:41 4391

Sands China Title Sponsors Macau GT Cup

MACAU, Nov. 22, 2021 /PRNewswire/ -- Sands China Ltd. was the title sponsor of this weekend'sSands China Macau GT Cup, which welcomed race car drivers from around the world to compete in the city's signature auto racing event, the Macau Grand Prix.

2021-11-22 15:31 4908

Chemours Files Second Lawsuit Against AGC, Inc. for Infringement of HFO-1234yf Patent

WILMINGTON, Del., Nov. 22, 2021 /PRNewswire/ -- On November 12, 2021, The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials and Chemical Solutions,announced tha...

2021-11-22 14:29 4807

Ericsson to acquire Vonage for USD 6.2 billion to spearhead the creation of a global network and communication platform for open innovation

- Ericsson enters into agreement for USD 6.2 billion cash offer to acquire Vonage, a global provider of cloud-based communications, with unanimous approval of the Vonage Board of Directors - Acquisition underlines Ericsson strategy to expand its presence in wireless enterprise and broaden its gl...

2021-11-22 14:22 3003

Kia teases the all-new Niro ahead of 2021 Seoul Mobility Show debut

* The all-new Niro to be unveiled at the Seoul Mobility Show, following Kia's announcement of becoming 'Sustainable Mobility Solutions Provider' * Niro inherits bold design elements from the 2019 Habaniro concept SEOUL, South Korea, Nov. 22, 2021 /PRNewswire/ -- Kia has revealed the first glim...

2021-11-22 11:00 2887

Breakthrough Chemotherapy Heart Protection Discovery for Australian Biotech

* Race Oncology's drug Zantrene shown to protect human heart muscle cells from anthracycline-induced chemotherapy death. Anthracycline's are the most used and effective anti-cancer drugs, yet they can cause serious heart damage. * The preclinical research also demonstrated Zantrene's ability t...

2021-11-22 09:24 3281

"Life's Good Film" Applauded, Recognized at International Film Festivals

SEOUL, South Korea, Nov. 22, 2021 /PRNewswire/ -- LG Electronics (LG) is proud to announce that the LG andJackson Tisi co-produced Life's Good Film took the prize for this month's Best Documentary Short at theIndie Short Fest , one of ei...

2021-11-22 09:00 2693

Innovent Releases the ORIENT-31 Phase 3 Study First Interim Analysis Results of Sintilimab plus BYVASDA (bevacizumab biosimilar injection) and Chemotherapy in Patients with EGFR-mutated Nonsquamous Non-small Cell Lung Cancer who Progressed After EGFR-TKI Therapy at ESMO Virtual Plenary 2021

SAN FRANCISCO and SUZHOU, China, Nov. 22, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2021-11-22 08:16 3921

Innovent Announces Inclusion of the Company's Stock (01801.HK) in the Hang Seng China Enterprises Index

SAN FRANCISCO and SUZHOU, China, Nov. 22, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2021-11-22 08:00 4358

CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China

SUZHOU, China, Nov. 21, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, and Jiangsu Hengrui Pharmaceuticals ("Hengru...

2021-11-21 17:09 4057